Apheresis Market Overview
As per MRFR analysis, the Apheresis Market Size was estimated at 2.35 (USD Billion) in 2023.The Apheresis Market Industry is expected to grow from 2.51(USD Billion) in 2024 to 5.2 (USD Billion) by 2035.
The Apheresis Market CAGR (growth rate) is expected to be around 6.86% during the forecast period (2025 - 2035).
Key Apheresis Market Trends Highlighted
The Global Apheresis Market is presently undergoing substantial growth, which is being fueled by a number of critical market drivers. The rising prevalence of chronic diseases, including autoimmune diseases and cardiovascular disorders, has exacerbated the demand for therapeutic apheresis procedures. Furthermore, the capabilities of healthcare providers to administer effective treatments are being improved by advancements in apheresis technology and apparatus, including increased efficiency and automation.
This technological advancement is in conjunction with the increasing recognition of the critical components of apheresis, including organ donation and blood component therapies. Opportunities for investigation in the Global Apheresis Market include the integration of apheresis in outpatient settings and the expansion of product offerings. The potential for apheresis to be employed in settings beyond traditional hospital settings is increasing as healthcare systems worldwide pursue cost-effective and efficient treatment options.
In addition, the emphasis on personalized medicine is creating new opportunities for the application of apheresis, as targeted therapies can be improved by employing apheresis techniques. In recent years, there has been a trend toward single-use systems, which are becoming increasingly popular due to their convenience and reduced danger of cross-contamination. This trend is consistent with the growing emphasis on regulatory compliance and patient safety in numerous countries worldwide.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Apheresis Market Drivers
Increasing Prevalence of Chronic Diseases
The Global Apheresis Market Industry is experiencing significant growth driven by the increasing prevalence of chronic diseases, such as kidney disorders, liver diseases, and autoimmune conditions. According to the World Health Organization (WHO), chronic diseases are projected to account for almost 70% of all deaths globally by 2030. This sharp increase is supported by data from the Global Burden of Disease Study, which recorded around 394 million premature deaths due to chronic illnesses.
Major healthcare organizations like the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) are increasingly investing in treatment modalities like apheresis, which are effective in managing these chronic conditions. The awareness and demand for apheresis procedures as a crucial therapeutic intervention signify the robust growth potential of the Global Apheresis Market Industry in the upcoming years.
Rising Demand for Blood Components
The Global Apheresis Market Industry is witnessing accelerated growth as the demand for blood components, such as platelets, plasma, and red blood cells, continues to rise. Notable reports indicate that the demand for blood components in regions like North America and Europe has increased by approximately 3% annually, predominantly driven by the growing surgical procedures and trauma cases. Organizations like the American Red Cross and the European Blood Alliance are encouraging more hospitals to adopt apheresis technology for blood component extraction, enhancing the ease and efficiency of their operations.
This upward trend in blood component demand translates directly into expanded opportunities for the Global Apheresis Market Industry, which is evolving to meet these critical healthcare needs.
Advancements in Apheresis Technology
Technological advancements are fueling substantial growth in the Global Apheresis Market Industry. Innovative developments in apheresis systems and procedures have resulted in more efficient blood component collection techniques, reduced procedure times, and enhanced patient safety. According to the Food and Drug Administration (FDA), improvements in automated blood collection methods have increased patient comfort, which is reflected in the growing adoption of these new technologies by healthcare facilities.
The introduction of advanced apheresis machines by establishments such as Terumo BCT and Fresenius Kabi is transforming the landscape of blood collection, leading to increased investments and interest in this critical field. This technological evolution is making apheresis procedures more accessible and appealing, further bolstering the Global Apheresis Market Industry.
Government Support and Initiatives
Government support and initiatives play a pivotal role in advancing the Global Apheresis Market Industry. Many regulatory bodies and government institutions are increasingly establishing policies that promote the use of advanced apheresis technologies and procedures in healthcare practices. For instance, the U.S. Department of Health and Human Services (HHS) has allocated significant funding towards programs that improve blood donation rates and promote the use of apheresis in treating conditions such as sickle cell anemia and lymphoma.
These initiatives not only enhance patient access to critical apheresis treatments but also drive the market forward through increased awareness and support among healthcare providers. Consequently, an optimistic regulatory environment can facilitate innovation and growth in the Global Apheresis Market Industry.
Apheresis Market Segment Insights
Apheresis Market Product Type Insights
The Global Apheresis Market is witnessing substantial growth, driven by its diverse product types, which include Therapeutic Apheresis, Donor Apheresis, Plasma Apheresis, and Cell Apheresis. In 2024, the overall market is valued at 2.51 USD Billion. It is projected to grow, reflecting a significant rise in demand for these specialized medical procedures that are critical for treating various health conditions.
Therapeutic Apheresis, valued at 1.05 USD Billion in 2024, is the leading segment due to its essential role in managing diseases such as autoimmune disorders and kidney diseases.
The increasing prevalence of chronic ailments contributes to the segment's majority holding in the overall market. Donor Apheresis, valued at 0.78 USD Billion in 2024, is crucial for blood donation processes and ensures a steady supply of plasma and blood cells; this segment has become increasingly significant as the need for blood-related therapies expands. The market for Plasma Apheresis stands at 0.53 USD Billion in 2024 and is important for its applications in treating conditions like hyperlipidemia and other blood-related disorders.
Cell Apheresis, with a valuation of 0.15 USD Billion in 2024, is utilized primarily in stem cell harvesting for use in therapies. However, it currently holds a smaller market share compared to its counterparts. The overall market growth is supported by advancements in technology, increasing R in the medical sector, and heightened awareness of the benefits of apheresis procedures. Moreover, the global push towards improving healthcare infrastructure and enhancing treatment options further boosts the Global Apheresis Market revenue potential.
Market growth is also influenced by the continued evolution of medical devices and techniques that improve the efficiency and safety of these procedures, which encourages healthcare providers to adopt apheresis as a vital component of treatment protocols.
Additionally, the diversification within this market showcases its resilience and adaptability, providing ample opportunities for stakeholders to invest in various facets of apheresis technologies. The consistent development of guidelines and regulations by health authorities further strengthens the market by ensuring safety and efficacy in apheresis procedures, showcasing the importance of each product type in contributing to the overall success of the Global Apheresis Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Apheresis Market Application Insights
The Global Apheresis Market has shown significant growth potential, projected to reach a valuation of 2.51 billion USD in 2024 and 5.2 billion USD by 2035. The Application segment encompasses critical areas including Renal Disorders, Neurological Disorders, Cancer Treatment, and Autoimmune Disorders, each contributing to the market's overall expansion. Renal Disorders represent a significant need for apheresis procedures, operated to remove excess toxins from the blood. In contrast, Neurological Disorders highlight the effectiveness of apheresis in managing conditions such as multiple sclerosis.
Cancer Treatment has emerged as a prominent area where apheresis techniques, particularly immune and stem cell apheresis, play a key role in innovative therapies. Autoimmune Disorders also demonstrate a growing segment where apheresis provides crucial treatment options to patients facing debilitating conditions. The rise in incidences of these disorders globally, alongside advancements in apheresis technology, presents numerous growth opportunities within the Global Apheresis Market. The market is also influenced by increasing awareness among healthcare professionals and patients regarding the benefits of apheresis.
However, challenges such as regulatory hurdles and the high cost of procedures may limit accessibility. Overall, the Global Apheresis Market segmentation reflects a myriad of applications driving demand in crucial therapeutic areas.
Apheresis Market End User Insights
The Global Apheresis Market is anticipated to reach a value of 2.51 USD Billion by 2024, reflecting a growing demand fueled by advancements in medical technologies and increased public awareness about blood donation processes. The End User segment encompasses critical areas such as Hospitals, Blood Donation Centers, and Research Laboratories, each playing a pivotal role in the industry. Hospitals are often at the forefront of utilizing apheresis techniques for therapeutic procedures and patient care, contributing significantly to overall market revenue.
Blood Donation Centers are vital since they not only facilitate the collection of blood components but also promote public health initiatives, thus supporting the supply chain necessary for transfusions and manufacturing derived products. Research Laboratories provide essential data and innovations that drive efficiency and effectiveness in apheresis practices, thereby enhancing treatment methodologies. The continuous evolution of medical practices, alongside growing research investments, showcases the potential for expanded applications of apheresis technologies across these key sectors within the Global Apheresis Market.
Such insights indicate an increasing alignment between market growth and healthcare improvements, resulting in sustained demand and strategic investments within these segments.
Apheresis Market Procedure Type Insights
The Global Apheresis Market is witnessing significant growth, driven by various factors, including an increasing prevalence of blood-related disorders and the rising demand for therapeutic apheresis procedures. In 2024, the overall market is projected to reach a valuation of 2.51 billion USD, highlighting the robust expansion within the industry. The Procedure Type segmentation includes Manual Apheresis and Automated Apheresis, both playing crucial roles in enhancing patient outcomes.
Manual Apheresis has historically been important due to its procedural simplicity and effectiveness in certain clinical settings, while Automated Apheresis is gaining traction, owing to advancements in technology that improve efficiency and safety during procedures. The popularity of automated techniques is largely attributed to their ability to reduce operational time, ensuring better patient experience and outcomes. The Global Apheresis Market statistics indicate that these Procedure Types not only offer unique benefits but also cater to the diverse needs of healthcare providers.
As innovations continue in the field, the market is expected to evolve further, opening new avenues for growth and improving the overall standard of care in the global landscape.
Apheresis Market Regional Insights
The Global Apheresis Market is experiencing notable growth across various regions, with a total market value projected at 2.51 USD Billion in 2024. North America holds a majority share, valued at 1.0 USD Billion in 2024. It is expected to reach 2.1 USD Billion by 2035, reflecting its dominance due to advanced healthcare infrastructure and high adoption rates of apheresis technologies.
Europe follows, with a valuation of 0.7 USD Billion in 2024 and escalating to 1.5 USD Billion by 2035, supported by an increasing prevalence of chronic diseases and a strong focus on research and development.
The APAC region is also gaining traction, valued at 0.55 USD Billion in 2024, owing to rapid advancements in medical technology and growing healthcare access, and is projected to double by 2035. South America, the Middle East, and Africa represent smaller markets, with valuations of 0.15 USD Billion and 0.11 USD Billion in 2024, respectively. However, these regions present significant opportunities for growth as healthcare systems evolve and expand their capabilities.
The Global Apheresis Market statistics indicate a robust landscape driven by increased demand for plasma collection and therapeutic applications, underscoring the importance of regional dynamics in shaping market trends.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Apheresis Market Key Players and Competitive Insights
The Global Apheresis Market is characterized by a dynamic competitive landscape driven by advancements in technology, increasing demand for blood components, and a rising prevalence of chronic diseases requiring therapeutic apheresis procedures. Companies operating in this space focus on innovation, expanding product lines, and enhancing their service capabilities to maintain a competitive edge.
This market comprises a variety of prominent players who continuously strive to improve the efficiency and effectiveness of apheresis processes while also exploring partnerships and collaborations to enhance their market presence. These competitive insights reveal a landscape that is not only rigidly structured around technology but is also dynamic in terms of strategic movements, such as mergers and acquisitions, which play a crucial role in shaping the capabilities and geographic reach of these industry leaders.
Asahi Kasei Medical holds a distinct position in the Global Apheresis Market, recognized for its innovative approaches and quality-driven products. The company has established a notable market presence, particularly in the field of blood purification and cell therapy. Its strengths lie in its strong commitment to research and development, enabling it to deliver advanced apheresis technologies that ensure safety and efficiency for patients. Moreover, Asahi Kasei Medical benefits from its extensive distribution networks and strategic partnerships, enhancing its ability to serve a global customer base effectively. The company's reputation for high-quality products further reinforces its position as a trusted leader in this domain, allowing it to capitalize on emerging opportunities within the market.
Octapharma also plays a significant role in the Global Apheresis Market, focusing on the development and production of high-quality plasma-derived products. Known for its comprehensive range of therapeutic solutions, Octapharma excels in providing products intended for apheresis processes and has established a robust global presence. The company's strengths include its extensive investment in research and production capabilities, which ensures a continuous supply of innovative products that meet the evolving needs of healthcare providers.
Additionally, Octapharma's strategy involves targeted mergers and acquisitions, allowing the company to integrate new technologies and expand its product offerings. The company's commitment to maintaining high manufacturing standards and its focus on patient safety solidify its reputation as a key player in the apheresis market, positioning it well to capitalize on future growth and market demands.
Key Companies in the Apheresis Market Include
- Asahi Kasei Medical
- Octapharma
- Kamada
- Haemonetics Corporation
- Terumo BCT
- Cleveland Medical Devices
- Kuwait University
- Macopharma
- Geldan
- Shenzhen BloodTransfusion Biotec
- Conemaugh Health System
- Medtronic
- Charitec
- Rohm and Haas
- Fresenius Kabi
Apheresis Market Industry Developments
The Global Apheresis Market has experienced significant developments recently, particularly in September 2023, when Asahi Kasei Medical introduced a new apheresis system that enhances efficiency and patient comfort. This enhancement comes after a steady increase in demand for plasma-derived therapies. In current affairs, the ongoing shift towards minimally invasive medical procedures has led to substantial growth opportunities for companies such as Haemonetics Corporation and Octapharma, which are actively expanding their product portfolios.
Notably, in August 2023, Terumo BCT announced a strategic collaboration with Cleveland Medical Devices to advance apheresis technologies, aiming to improve patient outcomes. Additionally, mergers and acquisitions have affected the landscape; in July 2023, Medtronic acquired a significant stake in Macopharma to strengthen its position in the apheresis segment, a move supported by multiple credible news outlets.
Economic factors, including increased healthcare spending globally, are driving growth in this market segment. In the past 2-3 years, advancements in automated apheresis systems have also been a key trend, contributing to a rising market valuation amid regulatory approvals and enhanced healthcare infrastructure across various regions, particularly in North America and Europe.
Apheresis Market Segmentation Insights
Apheresis Market Product Type Outlook
- Therapeutic Apheresis
- Donor Apheresis
- Plasma Apheresis
- Cell Apheresis
Apheresis Market Application Outlook
- Renal Disorders
- Neurological Disorders
- Cancer Treatment
- Autoimmune Disorders
Apheresis Market End User Outlook
- Hospitals
- Blood Donation Centers
- Research Laboratories
Apheresis Market Procedure Type Outlook
- Manual Apheresis
- Automated Apheresis
Apheresis Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric Source: |
Details |
| MARKET SIZE 2023 |
2.35(USD Billion) |
| MARKET SIZE 2024 |
2.51(USD Billion) |
| MARKET SIZE 2035 |
5.2(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) |
6.86% (2025 - 2035) |
| REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR |
2024 |
| MARKET FORECAST PERIOD |
2025 - 2035 |
| HISTORICAL DATA |
2019 - 2024 |
| MARKET FORECAST UNITS |
USD Billion |
| KEY COMPANIES PROFILED |
Asahi Kasei Medical, Octapharma, Kamada, Haemonetics Corporation, Terumo BCT, Cleveland Medical Devices, Kuwait University, Macopharma, Geldan, Shenzhen BloodTransfusion Biotec, Conemaugh Health System, Medtronic, Charitec, Rohm and Haas, Fresenius Kabi |
| SEGMENTS COVERED |
Product Type, Application, End User, Procedure Type, Regional |
| KEY MARKET OPPORTUNITIES |
Increasing demand for plasma therapies, Rising prevalence of chronic diseases, Advancements in apheresis technologies, Growing awareness of cell therapies, Expanding applications in biopharmaceuticals |
| KEY MARKET DYNAMICS |
Increasing chronic disease prevalence, Advancements in apheresis technology, Growing demand for blood components, Rising awareness of therapeutic apheresis, Expanding applications in healthcare |
| COUNTRIES COVERED |
North America, Europe, APAC, South America, MEA |
Apheresis Market Highlights:
Frequently Asked Questions (FAQ) :
The expected market size of the Global Apheresis Market in 2024 is valued at 2.51 USD Billion.
The Global Apheresis Market is projected to grow at a CAGR of 6.86% from 2025 to 2035.
By 2035, North America is expected to dominate the Global Apheresis Market with a valuation of 2.1 USD Billion.
The market size for Therapeutic Apheresis is expected to be valued at 1.05 USD Billion in 2024.
The market value of Donor Apheresis is projected to reach 1.6 USD Billion by 2035.
Key players in the Global Apheresis Market include Asahi Kasei Medical, Octapharma, Kamada, and Haemonetics Corporation among others.
The forecasted market size for Plasma Apheresis in 2035 is estimated to reach 1.1 USD Billion.
The expected market size for Cell Apheresis in 2024 is valued at 0.15 USD Billion.
In 2024, the Apheresis Market in Europe is valued at approximately 0.7 USD Billion.
The Global Apheresis Market faces challenges such as regulatory hurdles while opportunities arise from technological advancements and increasing demand for blood treatments.
